MedTrace Logo

A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).

NCT05090345 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-04-20

No results posted yet for this study

Summary

This is a prospective international multi-center registry and biorepository trial of children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.

Conditions

  • Hematopoietic Cell Transplantation

Interventions

OTHER

Biorepository Trial

participating in this arm, peripheral blood specimen(s) will be obtained at 8 specified time-points.

Sponsors & Collaborators

Principal Investigators

  • Kris Mahadeo · Duke University

Eligibility

Min Age
0 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-19
Primary Completion
2026-02-05
Completion
2026-02-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090345 on ClinicalTrials.gov